Beaulieu D, Tang J, Yan S B, Vessels J M, Radding J A, Parr T R
Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, Indiana 46285.
Antimicrob Agents Chemother. 1994 May;38(5):937-44. doi: 10.1128/AAC.38.5.937.
(1,3)-beta-D-Glucan synthase, a major cell wall synthesis enzyme, is the target of antifungal drugs of the lipopeptide class. Aspergillus fumigatus (1,3)-beta-D-glucan synthase was prepared and its activity was measured by incorporation of [14C]glucose from UDP-[U-14C]glucose into an insoluble polymer in the presence of alpha-amylase. Solubilization of the (1,3)-beta-D-glucan synthase was attempted with several detergents, and the maximum percent solubilization was obtained with a polyoxyethylene ether detergent, W-1. Up to 70% of enzyme activity and 50% of total protein were recovered when 1-mg/ml membrane preparations were extracted with 0.045% W-1 at 4 degrees C overnight. Confirmation of the presence of a (1,3)-beta-D-glucose polymer synthesized by this glucan synthase was done by three methods. The first was enzymatic end product degradation by alpha-amylase (no degradation) and beta-glucanase (85 to 95% degradation). The second was gas chromatography-mass spectroscopy analysis of the partially methylated alditol acetate derivatives prepared from total carbohydrate polymers present in the sample. This method identified the presence of (1,3)- and (1,2)-glucosidic linkages. The third was high-performance anion exchange chromatography of radioactive oligosaccharides. This method allowed differentiation of the newly synthesized, radioactive polymers from the contaminating carbohydrates already present in the preparation. The results showed that the polymer synthesized comprised oligosaccharides consistent with beta-(1,3)-linked sugars. Maximal inhibition of the (1,3)-beta-D-glucan synthase by the lipopeptide antifungal agent cilofungin was 80%. Dose-response experiments with this inhibitor showed that the solubilized enzyme was maximally inhibited at a cilofungin concentration of 1.25 microgram/ml and showed <5% inhibition at 0.02 microgram/ml. The apparent K(m) (K(m app)) for the solubilized glucan synthase was 400 +/- 80 microM, and the apparent K(i) (K(i app)) for cilofungin was 0.19 +/- 0.03 microM. Inhibition of A.fumigatus (1,3)-beta-D-glucan synthase with cilofungin was noncompetitive, as it was for the Candida albicans (1,3)-beta-D-glucan synthase.
(1,3)-β-D-葡聚糖合酶是一种主要的细胞壁合成酶,是脂肽类抗真菌药物的作用靶点。制备了烟曲霉(1,3)-β-D-葡聚糖合酶,并通过在α-淀粉酶存在下将UDP-[U-14C]葡萄糖中的[14C]葡萄糖掺入不溶性聚合物中来测定其活性。尝试用几种去污剂溶解(1,3)-β-D-葡聚糖合酶,用聚氧乙烯醚去污剂W-1获得了最大溶解百分比。当用0.045%W-1在4℃下过夜提取1mg/ml膜制剂时,可回收高达70%的酶活性和50%的总蛋白。通过三种方法证实了由该葡聚糖合酶合成的(1,3)-β-D-葡萄糖聚合物的存在。第一种方法是通过α-淀粉酶(无降解)和β-葡聚糖酶(85%至95%降解)进行酶促终产物降解。第二种方法是对样品中存在的总碳水化合物聚合物制备的部分甲基化糖醇乙酸酯衍生物进行气相色谱-质谱分析。该方法鉴定出存在(1,3)-和(1,2)-糖苷键。第三种方法是对放射性寡糖进行高效阴离子交换色谱分析。该方法能够将新合成的放射性聚合物与制剂中已存在的污染性碳水化合物区分开来。结果表明,合成的聚合物包含与β-(1,3)-连接的糖一致的寡糖。脂肽类抗真菌剂西洛芬净对(1,3)-β-D-葡聚糖合酶的最大抑制率为80%。用该抑制剂进行的剂量反应实验表明,溶解的酶在西洛芬净浓度为1.25μg/ml时受到最大抑制,在0.02μg/ml时抑制率<5%。溶解的葡聚糖合酶的表观K(m)(K(m app))为400±80μM,西洛芬净的表观K(i)(K(i app))为0.19±0.03μM。西洛芬净对烟曲霉(1,3)-β-D-葡聚糖合酶的抑制作用是非竞争性的,白色念珠菌(1,3)-β-D-葡聚糖合酶的情况也是如此。